20-Year review aims to improve surgery for rare childhood kidney cancer
NCT ID NCT05195411
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looked back at 72 children treated for Wilms tumor (a kidney cancer) that had spread into the vena cava, the large vein carrying blood to the heart. Researchers reviewed medical records from 1999 to 2019 to understand how surgery was managed and what complications occurred. The goal is to create better surgical guidelines for this rare and complex condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to clear surgical guidelines for treating children with Wilms tumor that has spread into the vena cava, potentially improving outcomes.
- What could go wrong
- This is a retrospective review of past cases, not a new treatment trial. It cannot prove that any specific approach works better than another.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
72 people
The number who actually took part.
- Started
-
Dec 2022
- Finished
-
Mar 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children with nephroblastoma with vena cava thrombosis +/- atrial extension cared between 1999 and 2019 in Parisian hospitals: Necker and Bicêtre.
- Ages
-
Up to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Minors with nephroblastoma with vena cava thrombosis +/- atrial extension. * Cared between 1999 and 2019 in the centers of the study. Exclusion Criteria: \- Other renal and non-renal tumors with vena cava thrombosis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Nephroblastoma with vena cava thrombosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Kremlin Bicêtre
Le Kremlin-Bicêtre, 94270, France
-
Hôpital Necker-Enfants Malades
Paris, 75015, France